ID: ALA156687

Max Phase: Preclinical

Molecular Formula: C15H15N

Molecular Weight: 209.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(N)c1ccc2c(c1)Cc1ccccc1-2

Standard InChI:  InChI=1S/C15H15N/c1-10(16)11-6-7-15-13(8-11)9-12-4-2-3-5-14(12)15/h2-8,10H,9,16H2,1H3

Standard InChI Key:  UXDIWHBDPJMNFD-UHFFFAOYSA-N

Associated Targets(non-human)

Phenylethanolamine N-methyltransferase 752 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 209.29Molecular Weight (Monoisotopic): 209.1204AlogP: 3.28#Rotatable Bonds: 1
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.51CX LogP: 3.28CX LogD: 1.22
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.65Np Likeness Score: -0.23

References

1. Grunewald GL, Carter AE, Sall DJ, Monn JA..  (1988)  Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase.,  31  (1): [PMID:3336033] [10.1021/jm00396a010]

Source